Over 100 Republicans Blast FDA Over Chemical Abortion Drug In Amicus Brief

  • A total of 147 Republicans in the United States Congress, including 23 senators and 124 members of the House of Representatives, filed an amicus brief asking the Supreme Court to deny an emergency application from the Biden administration’s FDA to stay an order by the United States District Court that stayed FDA approval of the abortion drug mifepristone.
  • Noting that the FDA approved and then deregulated chemical abortion drugs, thus failing to follow Congress’ drug approval process and subverting Congress’ public policy interests in upholding patient welfare, the brief pointed out that the FDA in 2016 “eliminated any requirement that adverse non-fatal medical events resulting from chemical abortion be reported to the FDA, then claimed in its 2021 revision that the absence of reported complications demonstrated that chemical abortion was safe.”
  • “Congress has also decreed that abortion-inducing drugs are ‘nonmailable matter’ by the United States Postal Service and common carriers, protecting women and girls from the heightened risks of mail-order chemical abortion drugs,” the brief added.